TEM slides sharply
The stock is extending its slide from the Recursion deal pop, with sellers in control and volume near normal, pointing to steady profit-taking rather than panic churn.
Sources: https://www.tokenpost.com/tag/tempus-ai, https://www.moneydj.com/kmdj/news/newsviewer.aspx?a=0192434c-9e08-4a77-ac44-d2a874fc0446, https://timothysykes.com/news/tempus-ai-inc-tem-new
Previous verdicts for TEM
- AI Search: TEM Slips Modestly as Profit-Taking Follows Recursion Rally — 2026-10-06
- AI Search: Tempus AI Spikes Sharply on ECG Valvular Screening Coverage — 2026-10-05
- FDA clearance lifts TEM — 2026-09-28
- Earnings beat lifts TEM — 2026-09-25
- TEM Surges Violently — 2026-09-24
Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works